Transarterial periarticular embolization (TAPE) in inflammatory rheumatic monoarthritis: a proof-of-concept study
Authors' conclusion
TAPE is a feasible, safe and well-tolerated treatment associated with clinically meaningful pain reduction in therapy-refractory inflammatory rheumatic monoarthritis.
Study context
- Population
- Patients with therapy-refractory inflammatory rheumatic monoarthritis or knee osteoarthritis (OA) treated with TAPE (imipenem/cilastatin); knees, ankles and one radiocarpal joint17 joints
- Participants
- 14 patients
- Comparison
- TAPE in inflammatory rheumatic monoarthritis vs knee OA
- Inflammatory rheumatic joint diseasen = 3
- Knee OAn = 11reference
- Outcome
- Pain (VAS), median
Main finding
As reported in the abstract
Median visual analogue scale (VAS) at baseline (IQR 3.00-6.00)
5.0
Median VAS at day 1 (IQR 0.0-3.0)
1.0
Median VAS at day 90 (IQR 0.00-4.25)
1.0
Further findings
Reduced periarticular circumference
- Patients with reduced periarticular circumference
- 70.6%
Improved joint range of motion
- Patients with improved joint range of motion
- 58.8%
Imaging (US and MRI, subset)
- Reduced synovitis and joint effusion in inflammatory cases
Technical success
- Technically successful in all patients
Safety
- No adverse events occurred
Original publication
TAPE in inflammatory rheumatic monoarthritis: a proof-of-concept study. Rheumatology (Oxford). Published 22 August 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →